Ditchcarbon
  • Contact
  1. Organizations
  2. Orifarm
Public Profile
Medical Device Manufacturing
DK
updated 2 months ago

Orifarm

Company website

Orifarm, officially known as Orifarm Group, is a prominent player in the pharmaceutical industry, headquartered in Denmark (DK). Founded in 1994, the company has established itself as a leader in the development, production, and distribution of generic medicines and parallel imports, primarily serving the European market. With a strong focus on quality and accessibility, Orifarm offers a diverse portfolio of products, including prescription medications and over-the-counter solutions. Their commitment to innovation and sustainability sets them apart in a competitive landscape. Over the years, Orifarm has achieved significant milestones, including expanding its operational reach across multiple European countries. The company is recognised for its dedication to improving patient access to essential medicines, solidifying its position as a trusted partner in the healthcare sector.

DitchCarbon Score

How does Orifarm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

68

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Orifarm's score of 68 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.

82%

Let us know if this data was useful to you

Orifarm's reported carbon emissions

In 2024, Orifarm Group A/S reported total carbon emissions of approximately 3,178,000 kg CO2e for Scope 1 and about 7,300,000 kg CO2e for Scope 2 (market-based). This reflects a slight decrease in Scope 1 emissions from 4,420,000 kg CO2e in 2023 and a reduction in Scope 2 emissions from 7,529,000 kg CO2e in the same year. The company has set ambitious targets to reduce its carbon footprint, aiming for a 30% reduction in both Scope 1 and Scope 2 emissions by 2025, using 2020 as the baseline. Looking towards the long term, Orifarm has committed to a significant reduction of 54.6% in absolute Scope 1 and 2 emissions by 2033, alongside a 32.5% reduction in Scope 3 emissions within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. Orifarm's climate strategy also includes a commitment to achieve net-zero emissions by 2050, with an emphasis on exponential reductions in absolute emissions. This commitment is part of a broader corporate responsibility framework, reflecting the company's dedication to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The emissions data and targets are cascaded from Orifarm Group A/S, which operates as a current subsidiary, ensuring that the company's climate commitments are integrated into its overall corporate strategy.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
732,000
000,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
575,000
000,000
000,000
000,000
0,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Orifarm's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Orifarm is in DK, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Orifarm is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

EurimPharm Arzneimittel GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

kohlpharma GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

axicorp GmbH

DE
•
Real estate services (70)
Updated 24 days ago

Concord Biotech

IN
•
Pharmaceutical Preparation Manufacturing
Updated 28 days ago

Medcor, Inc.

US
•
Health and social work services (85)
Updated 16 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251009.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy